EN
简体
繁体
EN
简体
繁体
About Us
Company Overview
Milestones
Our Team
Investors
Partnership & Recognition
Contact Us
CANbridge in Rare Disease Community
Pipeline & Products
Pipeline
Rare Oncology
Rare Diseases
Gene Therapy
Other Onc.
Approved Products
Hunterase®
Nerlynx®
Caphosol®
Investors
Information Disclosure
Listing Documents
Financial Reports
Announcements & Circulars
Corporate Governance
Stock Information
Presentations & Webcasts
Analyst Coverage
Financial Calendar
Email Alert and IR Contact
Media & News
Media Reports
Press Release
Corporate Culture & Career
Corporate Culture
Open Positions
Webcasts
CAN106 Phase 1b Update Call
Jun 27, 2023
LIVMARLI® Mainland China Approval Call
Jun 07, 2023
2022 Annual Results Webcast
Mar 31, 2023
2022 Interm Results Webcast
Aug 25, 2022
Jefferies Healthcare Conference
June 8-10, 2022
Presentations
Corporate Presentations
Sep 2023
2023 Interim Result Presentation
Aug 31, 2023
2022 Annual Result Presentation
Mar 31, 2023
2022 Interim Result Presentation
Aug 25, 2022
2021 Annual Result Presentation
Mar 23, 2022
